Where does Fred Craves work?

Fred Craves is Managing Director at Bay City Capital and Board director at Twist Bioscience and Board director at Madrigal and Board director at Dermira.

What does Fred Craves invest in?

Fred Craves invests in Biotech, Digital Health.

Fred Craves

Investor

Managing Director at Bay City Capital · Board director at Twist Bioscience · Board director at Madrigal · Board director at Dermira

San Francisco, CA

Find your path to Fred

31 people in our graph share verified history with Fred — schools, employers, funds. One of them is your warm intro.

Min CuiunlockedFred: together at Bay City Capital (2006–2011)

×5Fred: together at Bay City Capital

×6Fred: together at Twist Bioscience

About

Fred Craves, PhD, founded Bay City Capital in 1997 and built it into a leading life science investment firm, backing nearly 100 companies. He has held senior roles including EVP of Schering Berlin, CEO of Berlex Biosciences, and founded Reliant Pharmaceuticals (sold to GlaxoSmithKline in 2007). He holds a BS in Biology from Georgetown and a PhD in Pharmacology and Toxicology from UCSF, and has been named to the Forbes Midas List.

Contact· self-published, not guessed

f•••@baycitycapital.comreveal

Likely email· guessed from name + firm domain, not firm-published

f•••@baycitycapital.comreveal100% confident

Invests in

BiotechDigital Health

Board director at Twist Bioscience

Intro paths

→

In turn, Fred can intro founders to Twist Bioscience's investors below.

Twist Bioscience's investors · 14

+ND CapitalWoodside · $540K – $5.4M checks 3E Bioventures CapitalPalo Alto ARCH Venture PartnersChicago · $50K – $250M checks · since 2015 Asset Management CompanyMenlo Park · $500K – $2M checks Bay City CapitalSan Rafael · $5M – $10M checks Black Opal VenturesNew York Dentsu VenturesTokyo iGlobe PartnersSingapore · $600K – $6M checks LionBirdTel Aviv · $200K – $500K checks NFXSan Francisco · $250K – $5M checks OMX VenturesLincolnshire Paladin Capital GroupWashington · $100K – $5M checks Prime PartnersTokyo Vital Venture CapitalWashington · $1M – $3M checks

Co-founders at Twist Bioscience

William Charles BanyaiExecutive Officer, Director, Promoter

Bill James PeckExecutive Officer, Promoter

Emily LeproustFounder

Emily M. LeproustChief Executive Officer and Chair of the Board

Board director at Madrigal

Intro paths

→

In turn, Fred can intro founders to Madrigal's investors below.

Madrigal's investors · 3

Avoro Capital AdvisorsNew York Bay City CapitalSan Rafael · $5M – $10M checks Foresite CapitalWest Hollywood · since 2016

Co-founders at Madrigal

Rebecca TaubFounder and Director

Board director at Dermira

Intro paths

→

In turn, Fred can intro founders to Dermira's investors below.

Dermira's investors · 8

Aisling CapitalNew York Bay City CapitalSan Rafael · $5M – $10M checks Canaan PartnersStamford · $500K – $20M checks Fidelity InvestmentsBoston Foresite CapitalWest Hollywood New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks Qiming HealthcareBellevue · since 2016 SR One Capital ManagementRedwood City · since 2018

Co-founders at Dermira

Thomas G. WiggansExecutive Officer, Director

Eugene A. BauerExecutive Officer, Director

Experience

Bay City CapitalOwnercurrent1997 — presentSan Francisco Bay Area

Investments

Board seats

IMIDomics Inc.KBP BiosciencesMadrigal PharmaceuticalsSynchronicity (formerly Reset Therapeutics)

Investor

DermiraIncyte PharmaceuticalsIon TorrentMedarexReliant PharmaceuticalsTwist Bioscience

Per the firm's website.

Colleagues at Bay City Capital

Carl Goldfischer

Advisor, MD at Bay City Capital

David Beier

Managing Director at Bay City Capital

Larry Clay

Professional Staff at Bay City Capital

Lionel Carnot

Advisor, MS, MBA at Bay City Capital

Manuel Lopez-Figueroa

Advisor, PhD at Bay City Capital

Matthew Kronmiller

Vice President at Bay City Capital

Susan Vuong

Professional Staff at Bay City Capital

Network1

Fay XingMentee

Scientific Partner at Panacea Venture

Investors connected to Fred in public investor directories — a warm-intro map.

Frequently asked questions

Who is Fred Craves?: Fred Craves, PhD, founded Bay City Capital in 1997 and built it into a leading life science investment firm, backing nearly 100 companies. He has held senior roles including EVP of Schering Berlin, CEO of Berlex Biosciences, and founded Reliant Pharmaceuticals (sold to GlaxoSmithKline in 2007). He holds a BS in Biology from Georgetown and a PhD in Pharmacology and Toxicology from UCSF, and has been named to the Forbes Midas List.
Where does Fred Craves work?: Fred Craves is Managing Director at Bay City Capital and Board director at Twist Bioscience and Board director at Madrigal and Board director at Dermira.
What does Fred Craves invest in?: Fred Craves invests in Biotech, Digital Health.
What boards does Fred Craves sit on?: Fred Craves holds tracked board seats at IMIDomics Inc., KBP Biosciences, Madrigal Pharmaceuticals, Synchronicity (formerly Reset Therapeutics).
What companies has Fred Craves invested in?: Investments tracked here include Dermira, Incyte Pharmaceuticals, Ion Torrent, Medarex, Reliant Pharmaceuticals, Twist Bioscience.